NuScale reports Q2 revenue declining to $75,000 while launching a $750M secondary share offering to fund operations.

NuScale Power (NYSE:SMR) shares fell 6% Tuesday to $8.66 as the small modular reactor developer processed a sharp decline in second-quarter 2026 revenue alongside a newly announced $750 million equity offering. The move extends a challenging period for the stock, which had already declined 35% year to date through Monday’s close.

The broader nuclear sector mirrored the weakness midday. Oklo (NYSE:OKLO) dropped 5% to $41.62, BWX Technologies (NYSE:BWXT) fell 2% to $167.41, and Fluor (NYSE:FLR) slipped 2% to $53.59.

NuScale reported Q2 2026 revenue of just $75,000, a 99.1% year-over-year plunge from $8.05 million. The contraction follows the late-2025 completion of Fluor’s FEED Phase 2 engineering work on the RoPower project, leaving no comparable billable scope to offset the timing gap.

Despite the revenue dip, the company closed the quarter with $1.9 billion in cash and investments, representing a $900 million increase from Q1 2026. This liquidity was primarily fueled by $984.5 million in net equity proceeds during the first half of 2026. Consequently, the Class A share count expanded from 318.5 million at year-end 2025 to 410.4 million by June 30. On August 11, NuScale filed to sell an additional $750 million in shares via an at-the-market offering. At roughly 14 times projected 2028 sales, the stock trades at a valuation that contrasts with net insider selling over the past 12 months.

CEO John Hopkins emphasized operational preparedness, stating, “We hold the only U.S. Nuclear Regulatory Commission design certification in the SMR industry… No one is better positioned to deliver carbon-free, 24/7 power on the shortest possible timeline.” Commercial SMR deployment remains targeted for the early 2030s. Interim revenue will continue to rely on irregular front-end engineering, licensing, and consulting contracts, meaning the steep quarterly decline reflects scheduling rather than fundamental business deterioration. Named initiatives include a 462 MWe deployment at a former coal site in Doicesti, Romania, and up to 6 GW of planned capacity across seven states for the Tennessee Valley Authority.

Year-to-date performance underscores the market’s differentiation between companies generating immediate revenue and those promising future reactors. Through Monday’s close, NuScale was down 35% and Oklo fell 39%, while BWX Technologies remained roughly flat at a 0.5% decline and Fluor gained 38%. The Fluor relationship highlights this dynamic: although Fluor served as NuScale’s EPC partner and largest shareholder, it completed the monetization of its stake in April 2026 while maintaining the contracting agreement. This separation of technological confidence from equity exposure stands in contrast to BWX Technologies, a revenue-generating supplier operating more than 11,000 employees across 19 manufacturing facilities.

Within the fuel-supply segment, Centrus Energy (NYSE MKT:LEU)—the only publicly traded proven uranium enricher—declined 24% year to date through Monday. Uranium and fuel-related equities have underperformed less severely than pre-revenue SMR developers. Similarly, the VanEck Uranium and Nuclear ETF (NYSE ARCA:NLR) fell just 5% year to date. Weighted toward established nuclear utilities and fuel suppliers rather than pre-revenue developers, the fund’s modest decline serves as a poor proxy for SMR-specific risk. For investors who would rather own the buildout than the developers, we have outlined five nuclear names, including utilities and fuel producers, in a free report. The ETF remains a narrow thematic vehicle with meaningful concentration and is not leveraged.

NuScale’s bull case hinges on $1.9 billion in liquidity, its exclusive NRC design certification, anchored TVA and Romanian projects, and a supply chain comprising more than 60 specialized partners. The bear case centers on $75,000 in quarterly revenue, aggressive share count expansion with another $750 million in filings, commercialization delayed until the early 2030s, and persistent insider selling. Given the pre-revenue profile and active dilution, position sizing in SMR should remain conservative.

Traders should monitor the drawdown pace of the at-the-market offering. Shareholders may also track whether new FEED contracts replace the RoPower gap and whether TVA or Romanian scopes transition into billable engineering work.

Contact [email protected] for any questions or corrections.